Tyers Asset Management LLC boosted its position in shares of MEDNAX Inc (NYSE:MD) by 15.0% during the 1st quarter, HoldingsChannel.com reports. The fund owned 113,960 shares of the company’s stock after buying an additional 14,840 shares during the quarter. Tyers Asset Management LLC’s holdings in MEDNAX were worth $3,096,000 as of its most recent filing with the Securities & Exchange Commission.
Other institutional investors and hedge funds have also recently modified their holdings of the company. Lazard Asset Management LLC boosted its holdings in shares of MEDNAX by 150.5% in the 1st quarter. Lazard Asset Management LLC now owns 1,390,670 shares of the company’s stock worth $37,784,000 after acquiring an additional 835,444 shares in the last quarter. Alphasimplex Group LLC boosted its holdings in shares of MEDNAX by 24.5% in the 1st quarter. Alphasimplex Group LLC now owns 48,693 shares of the company’s stock worth $1,323,000 after acquiring an additional 9,570 shares in the last quarter. Sapience Investments LLC acquired a new position in shares of MEDNAX in the 1st quarter worth approximately $8,780,000. Hancock Whitney Corp boosted its holdings in shares of MEDNAX by 2.3% in the 1st quarter. Hancock Whitney Corp now owns 116,092 shares of the company’s stock worth $3,154,000 after acquiring an additional 2,570 shares in the last quarter. Finally, Neuberger Berman Group LLC acquired a new position in shares of MEDNAX in the 1st quarter worth approximately $11,210,000. Hedge funds and other institutional investors own 91.19% of the company’s stock.
NYSE:MD traded down $0.40 during trading hours on Wednesday, hitting $25.95. 20,343 shares of the stock were exchanged, compared to its average volume of 1,146,217. MEDNAX Inc has a twelve month low of $24.30 and a twelve month high of $48.77. The company has a debt-to-equity ratio of 0.79, a quick ratio of 2.55 and a current ratio of 2.55. The company has a market cap of $2.28 billion, a price-to-earnings ratio of 7.38, a P/E/G ratio of 1.01 and a beta of 0.66.
MD has been the topic of several recent analyst reports. Credit Suisse Group reduced their target price on MEDNAX from $44.00 to $42.00 and set an “outperform” rating on the stock in a report on Wednesday, February 13th. Jefferies Financial Group reduced their target price on MEDNAX from $37.00 to $31.00 and set a “hold” rating on the stock in a report on Thursday, April 11th. Zacks Investment Research downgraded MEDNAX from a “hold” rating to a “sell” rating in a report on Monday, April 22nd. Finally, Citigroup set a $36.00 target price on MEDNAX and gave the stock a “buy” rating in a report on Friday, May 3rd. Three investment analysts have rated the stock with a sell rating, seven have issued a hold rating and three have assigned a buy rating to the company’s stock. MEDNAX presently has an average rating of “Hold” and a consensus price target of $40.55.
COPYRIGHT VIOLATION WARNING: “Tyers Asset Management LLC Raises Position in MEDNAX Inc (NYSE:MD)” was posted by Sports Perspectives and is the property of of Sports Perspectives. If you are accessing this story on another site, it was illegally copied and republished in violation of international copyright law. The correct version of this story can be accessed at https://sportsperspectives.com/2019/06/12/tyers-asset-management-llc-raises-position-in-mednax-inc-nysemd.html.
MEDNAX, Inc, together with its subsidiaries, provides newborn, anesthesia, maternal-fetal, radiology and teleradiology, pediatric cardiology, and other pediatric subspecialty physician services in the United States and Puerto Rico. It offers neonatal care services, such as clinical care to babies born prematurely or with complications within specific units at hospitals through neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians; anesthesia and anesthesia subspecialty care services; and acute and chronic pain management services.
Read More: The Structure of a Futures Contract
Want to see what other hedge funds are holding MD? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for MEDNAX Inc (NYSE:MD).
Receive News & Ratings for MEDNAX Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MEDNAX and related companies with MarketBeat.com's FREE daily email newsletter.